皮下注射免疫球蛋白的发展及临床应用(5)
[14]OCHS HD.GUPTA S，KIESSLING P，et al. Safety and efficacy of self-administered subcutaneous immunoglobulinin patients with primary immunodeficiency diseases[J]. JClin Immunol， 2006， 26(3 ) ： 265-273.[15]NICOLAY U， KIESSLING P， BERGER M， et al. Health-related quality of life and treatment satisfaction in NorthAmerican patients with primary immunedeficiency diseas-es receiving subcutaneous IgG self-infusions at home[J]. JClin/mmuno/ ......
您现在查看是摘要页，全文长 2629 字符。